Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06566898 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Monitoring of Antimicrobial Resistance Based on Metagenomics Analyses in Pneumonia Patients

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date changed from estimate of Dec 30, 2025 to Apr 15, 2026
    • Study completion date: May 30, 2026 to Sep 30, 2026
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Monitoring of antimicrobial resistance (AMR) based on metagenomics analyses in pneumonia patients is critical for optimizing clinical diagnosis and treatment and improving clinical prognosis. This study is designed to ask the following key questions: 1. What is the microbiome maps of patients with severe pneumonia and mild pneumonia ? 2. How many pathogen resistance genes are carrying in severe pneumonia and mild pneumonia ? 3. What is the genetic diversity of key pathogens detected in severe pneumonia and mild pneumonia during 2019-2025?
Trial Details
NCT Number NCT06566898
Lead Sponsor Shanghai General Hospital, China
Collaborators: Wuxi People's Hospital Affiliated to Nanjing Medical University, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, The Central Hospital of Huanggang
Conditions
(from sponsor)		 Pneumonia, Next-generation Sequencing, Microbiome, Antimicrobial Resistance
Related terms Pneumonia
Enrollment 800 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov